Modern Diagnostic & Research Centre Limited (BOM:544673)
India
· Delayed Price · Currency is INR 67.45
-3.55 (-5.00%)
At close: Mar 9, 2026
BOM:544673 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Operating Revenue | 804.58 | 779.45 | 671.31 | 562.82 | 602.07 |
| Other Revenue | 9.89 | 8.18 | 15.11 | 1.21 | 0.02 |
| Revenue | 814.48 | 787.64 | 686.42 | 564.03 | 602.09 |
| Revenue Growth (YoY) | 35.27% | 14.75% | 21.70% | -6.32% | - |
| Cost of Revenue | 196.78 | 188.15 | 176.39 | 175.24 | 212.77 |
| Gross Profit | 617.69 | 599.49 | 510.02 | 388.78 | 389.32 |
| Selling, General & Admin | 254.74 | 242.01 | 224.22 | 227.97 | 182.48 |
| Other Operating Expenses | 163.12 | 169.67 | 159.42 | 169.48 | 146.66 |
| Operating Expenses | 461.1 | 453.58 | 422.87 | 436.12 | 365.74 |
| Operating Income | 156.59 | 145.91 | 87.15 | -47.34 | 23.58 |
| Interest Expense | -18.65 | -18.55 | -17.86 | -13.83 | -14.26 |
| Interest & Investment Income | 0.27 | 0.28 | 0.3 | 0.87 | 3.6 |
| Currency Exchange Gain (Loss) | 0.07 | 0.08 | 0 | 0.5 | 0.11 |
| Other Non Operating Income (Expenses) | -2.97 | -0.53 | -0.2 | -0.28 | -1.41 |
| EBT Excluding Unusual Items | 135.31 | 127.19 | 69.4 | -60.07 | 11.62 |
| Gain (Loss) on Sale of Assets | 0.02 | 0.05 | -0.75 | 0.65 | -0.24 |
| Pretax Income | 135.33 | 127.24 | 68.64 | -59.42 | 11.38 |
| Income Tax Expense | 40.45 | 37.56 | 10.69 | -2.1 | 25.89 |
| Net Income | 94.89 | 89.68 | 57.95 | -57.32 | -14.51 |
| Net Income to Common | 94.89 | 89.68 | 57.95 | -57.32 | -14.51 |
| Net Income Growth | - | 54.76% | - | - | - |
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 |
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 |
| EPS (Basic) | 8.63 | 8.15 | 5.27 | -5.21 | -1.32 |
| EPS (Diluted) | 8.63 | 8.15 | 5.27 | -5.21 | -1.32 |
| EPS Growth | - | 54.71% | - | - | - |
| Free Cash Flow | -74.43 | 5.73 | -31.04 | -34.53 | -15.92 |
| Free Cash Flow Per Share | -6.77 | 0.52 | -2.82 | -3.14 | -1.45 |
| Gross Margin | 75.84% | 76.11% | 74.30% | 68.93% | 64.66% |
| Operating Margin | 19.23% | 18.52% | 12.70% | -8.39% | 3.92% |
| Profit Margin | 11.65% | 11.39% | 8.44% | -10.16% | -2.41% |
| Free Cash Flow Margin | -9.14% | 0.73% | -4.52% | -6.12% | -2.64% |
| EBITDA | 198.25 | 186.23 | 124.45 | -8.74 | 60.1 |
| EBITDA Margin | 24.34% | 23.64% | 18.13% | -1.55% | 9.98% |
| D&A For EBITDA | 41.66 | 40.32 | 37.3 | 38.6 | 36.52 |
| EBIT | 156.59 | 145.91 | 87.15 | -47.34 | 23.58 |
| EBIT Margin | 19.23% | 18.52% | 12.70% | -8.39% | 3.92% |
| Effective Tax Rate | 29.89% | 29.52% | 15.58% | - | 227.55% |
| Revenue as Reported | 813.13 | 788.05 | 686.72 | 566.05 | 605.79 |
| Advertising Expenses | - | 6.37 | 5.62 | 2.15 | 4.84 |
Source: S&P Capital IQ. Standard template. Financial Sources.